hotspot -WSS

hotspot

author：entertainment 2025-09-27 13:04:03 - browse：5356

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Overprescribed: High cost isn't America's only drug problem

focus

WSS

Scientific mystery highlights the blind spots in genomics databases

U.K. decision on ALS drug has neurologists, advocates up in arms

Oral obesity drug from Viking Therapeutics hits key early target

Pancreatic cancer is often deadly, but new discoveries are raising hope

The a glaring gap in research on serious mental illness and primary care

Trial using CRISPR to edit HIV out of cells disappoints

focus

hotspot

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

FDA approves Sage Therapeutics’ rapid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Gut bacteria may contribute to kidney autoimmunity, study finds

Cancer drug shortages should be causing more outrage

Overprescribed: High cost isn't America's only drug problem

Cancer drug shortages should be causing more outrage

People with mental disorders often marry others with same

23andMe had bad news about my health. I wish a person had delivered it

Pancreatic cancer is often deadly, but new discoveries are raising hope

leisure time

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Overprescribed: High cost isn't America's only drug problem

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Flint parents haunted by uncertainty, fears of lead poisoning

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

UnitedHealth, in a surprise, takes aim at Steward’s physician group

knowledge

focus

entertainment

explore